INVIVOSCRIBE INC.

In News

System, an Integrated Sample Preparation Platform that Standardizes and Streamlines Pre-Analytical Workflows - Business Wire

Business Wire - Apr 15, 2026

Invivoscribe Begins Commercial Shipments of PrepQuant ™ Systems, Enabling High-Sensitivity Sample Preparation for MRD Testing - Via TT

Via TT - Sep 02, 2026

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia - Nature

Nature - Nov 24, 2025

Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification - Business Wire

Business Wire - Mar 26, 2026

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine - PR Newswire

PR Newswire - May 09, 2022

Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA - PR Newswire Canada

PR Newswire Canada - Jul 21, 2023

Cancer Biomarkers Market Report 2026-2032, By Product, Profiling Technology, and Geo - MarketsandMarkets

MarketsandMarkets - May 18, 2026

Biomarkers Consortium – Measurable residual disease in acute myeloid leukemia (MRD in AML) - FNIH

FNIH - Jun 06, 2023

Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia - PR Newswire

PR Newswire - Jul 14, 2020

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML - PR Newswire Canada

PR Newswire Canada - Aug 16, 2022

Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay - Via TT

Via TT - Apr 22, 2025

Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia - Nature

Nature - Oct 18, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment